Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure

American Heart Journal

Volumn 135, Issue 2 I, 1998, Pages 237-241

  Krum, H ^a   Karrasch, J ^a   Hamer, A ^a   Hare, D ^a   Howes, L G ^a   Jackson, B ^a   Leslie, P ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; QUINAPRIL;

AGED; ARTICLE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VERTIGO;

EID: 0031887686     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(98)70087-0     Document Type: Article

References (13)

1. K Chatterjee WW Parmley JN Cohn A cooperative multicentre study of captopril in congestive heart failure: hemodynamic effects and long-term response Am Heart J 110 1985 439 447
2. GAJ Reigger the Quinapril Research Group Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure Eur Heart J 12 1991 705 711
3. CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative Northern Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
4. SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular fractions N Engl J Med 327 1992 685 691
5. HL Elliott NJ MacDonald PA Meredith JL Reid Dose responses and pharmacokinetics for the angiotensin converting enzyme inhibitor quinapril Clin Pharmacol Ther 51 1992 260 265
6. JGF Cleland PA Poole-Wilson ACE inhibitors for heart failure: a question of dose Br Heart J 72 1994 106 110
7. SC Olson AM Horvath BD Michniewicz AJ Sedman WA Colburn PG Welling The clinical pharmacokinetics of quinapril Angiology 40 1989 351 359
8. DL Hare CR Davis Cardiac depression scale: validation of a new depression scale for cardiac patients J Psychosom Res 40 1996 379 386
9. M Yushak N Medina H Krum Utility of direct symptom assessment in measuring the efficacy of therapy in chronic heart failure: evaluation in a controlled trial of beta-blockade (abstract) J Am Coll Cardiol 24 1994 383A
10. K Lindpainter D Ganten The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence Circ Res 68 1991 905 921
11. AG Scicli R Farhy G Scicli H Nolly The kallikrein-kinin system in heart and vascular tissue G Bonner BA Scholkens AG Scicli The role of bradykinin in the cardiovascular action of ramipril 1992 Media Medica Chichester 17 27
12. GB Mancini GC Henry MS Macaya BJ O'Neill Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study Circulation 94 1996 258 265
13. DB Northridge E Rose ED Raftery A multicentre, double-blind placebo-controlled trial of quinapril in mild, chronic heart failure Eur Heart J 14 1993 403 409